THE RELATIONSHIP BETWEEN NUTRITIONAL-STATUS AND SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR CONCENTRATIONS IN PATIENTS WITH CROHNS-DISEASE TREATED WITH ELEMENTAL DIET

被引：4

作者：

DUANE, PD

TEAHON, K

CRABTREE, JE

LEVI, AJ

HEATLEY, RV

BJARNASON, I

机构：

[1] Department of Medicine, St. James's University Hospital, Leeds

[2] Gastroenterology Department, Northwick Park Hospital, Harrow, Middlesex

来源：

CLINICAL NUTRITION | 1991年 / 10卷 / 04期

关键词：

D O I：

10.1016/0261-5614(91)90042-B

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

Serum soluble interleukin-2 receptor concentrations (sIL-2R) were measured and correlated with indices of disease activity and nutrition in 13 patients with active Crohn's disease treated with an elemental diet. The initial serum sIL-2R concentrations were raised, 1121 +/- 181 U/ml (mean +/- SEM) compared to controls, 177 +/- 22.9 U/ml (n = 18) (p < 0.001). Four weeks' treatment resulted in significant improvement in disease activity (Harvey-Bradshaw index) and 4-day faecal Indium-111-leucocyte excretion. Serum sIL-2R concentrations did not change significantly after treatment, 789 +/- 79.8 U/ml (p > 0.05). Serum sIL-2R concentrations were inversely correlated with albumin, pre-albumin, creatinine-height index and total body potassium. Only those patients with markedly elevated sIL-2R concentrations (> 800 U/ml) and severe nutritional depletion prior to treatment, showed significant reductions in sIL-2R levels with elemental dietary treatment. These results demonstrate an association between nutritional impairment and immune activation in Crohn's disease.

引用

页码：222 / 227

页数：6

共 28 条

[1] O Morain, Segal, Levi, Elemental diets as primary treatment of acute Crohn's disease: a controlled trial, British Medical Journal, 288, pp. 1859-1862, (1984)
[2] Teahon, Bjarnason, Pearson, Levi, Ten years' experience with an elemental diet in the management of Crohn's disease, Gut, 31, pp. 1133-1137, (1990)
[3] Rhodes, Rose, Does food affect acute inflammatory bowel disease? The role of parenteral nutrition, elemental and exclusion diets, Gut, 27, pp. 471-474, (1986)
[4] Heatley, Smart, Danis, Inflammatory bowel disease, Gut defences in clinical practice, pp. 255-277, (1986)
[5] Ferguson, Why study T cell subsets in Crohn's disease?, Gut, 24, pp. 687-691, (1983)
[6] Smith, Interleukin-2, Annual Review of Immunology, 2, pp. 319-333, (1984)
[7] Leonard, Depper, Robb, Et al., Characterization of the human receptor for T cell growth factor, Proceedings of the National Academy of Sciences, 80, pp. 6957-6961, (1983)
[8] Wang, Smith, The interleukin-2-receptor: functional consequences of its bimolecular structure, Journal of Experimental Medicine, 166, pp. 1055-1069, (1987)
[9] Rubin, Kurman, Fritz, Et al., Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro, Journal of Immunology, 135, pp. 3172-3177, (1985)
[10] Symons, Wood, Di Giovine, Duff, Soluble IL-2 receptor in rheumatoid arthritis: correlation with disease activity, IL-1 and IL-2 inhibition, Journal of Immunology, 141, pp. 2612-2618, (1988)

← 1 2 3 →